Skip to content
OpenCapital
Get started

Dyne Therapeutics, Inc. DYN Cash ratio

Cash ratio at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
0.2×-0.8×
Arrowhead Research logo
Arrowhead ResearchARWR
0.6×-0.2×
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
1.5×-0.9×
PTC Therapeutics logo
PTC TherapeuticsPTCT
0.9×-1.6×
Scholar Rock logo
Scholar RockSRRK
7.2×+3.5×
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
5.7×+0.5×

Other financials

Income statement

See full
Operating income-$125.3M-2.4%
Net income-$120.9M-4.8%
EPS (diluted)-$0.73+30.5%

Balance sheet

See full
Cash & equivalents$753.1M+59.5%
Total debt$168.7M+623%
Total equity$865.1M+29.3%
Total assets$1.1B+49.8%

Cash flow

See full
Operating cash flow-$144.9M-36.9%
CapEx$221.0K-77.5%
Free cash flow-$145.1M-35.8%

Valuation

See full
Market cap$3.35B+153%

Returns & leverage

See full
Return on equity-58.9%-4.4pp
Debt / equity0.2×+0.2×
Current ratio19.9×-0.4×

Where this comes from

Calculated from Dyne Therapeutics, Inc.’s reported figures.

cash and equivalents/total current liabilities=14.7×

Based on the most recent quarter.

The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dyne Therapeutics, Inc.'s cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dyne Therapeutics, Inc.'s cash ratio?
Dyne Therapeutics, Inc. (DYN) reported cash ratio of 14.7× in Q1 2026.
How has Dyne Therapeutics, Inc.'s cash ratio changed year-over-year?
Dyne Therapeutics, Inc.'s cash ratio increased by 5.4% year-over-year, from 13.9× to 14.7×.
What is the long-term trend for Dyne Therapeutics, Inc.'s cash ratio?
Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s cash ratio has grown at a -8.4% compound annual growth rate (CAGR), from 27.4× to 17.6×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.